India's Breast Cancer Survival Rate is improving, offering hope to thousands of women. However, the country still trails many high-income nations. A new World Health Organization (WHO) report shows that India's five-year survival rate has reached...
Artificial intelligence is rapidly transforming the Indian pharmaceutical landscape, enabling faster, more accurate, and cost-efficient drug development processes
Differentiated products in India are gaining strong momentum as pharmaceutical companies are increasingly focusing on innovation-led drug development to meet medical needs
With the emergence of new risks in the routine and complex surgical procedures, the threat of antibiotic resistance is increasingly attracting public awareness
Mankind Pharma has approved two major strategic decisions to sharpen its long-term growth strategy. The company will sell its hospitality business for Rs49 crore.
India's NHM Webinar Series could become a key platform for improving public health across the country.
The Data Protection debate has returned to the spotlight as global pharmaceutical companies renew their demand for stronger regulatory safeguards in India.
The Drug manufacturers sector could see a major regulatory change in the United States. The US FDA has proposed a new rule to simplify registration for certain companies using distributed manufacturing models.
India’s pharmaceutical sector witnessed a dynamic week marked by drug innovation, regulatory tightening, global collaborations, and infrastructure investments
Reproductive rights have come sharply into focus in India as the National Commission for Women (NCW) initiates a comprehensive review of the regulatory framework
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")